A. H. Tulusan

454 total citations
28 papers, 276 citations indexed

About

A. H. Tulusan is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, A. H. Tulusan has authored 28 papers receiving a total of 276 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cancer Research, 9 papers in Oncology and 7 papers in Pathology and Forensic Medicine. Recurrent topics in A. H. Tulusan's work include Breast Cancer Treatment Studies (13 papers), HER2/EGFR in Cancer Research (5 papers) and Breast Lesions and Carcinomas (5 papers). A. H. Tulusan is often cited by papers focused on Breast Cancer Treatment Studies (13 papers), HER2/EGFR in Cancer Research (5 papers) and Breast Lesions and Carcinomas (5 papers). A. H. Tulusan collaborates with scholars based in Germany, United States and Austria. A. H. Tulusan's co-authors include E. Burghardt, Josef Haas, H. Egger, Guido Brandt, F Willgeroth, Christian Wülfing, Horst Buerger, W. Jäger, E Wolff and P Wülfing and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and British Journal of Cancer.

In The Last Decade

A. H. Tulusan

25 papers receiving 261 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. H. Tulusan Germany 9 108 79 78 73 57 28 276
R Nakashima Japan 8 117 1.1× 56 0.7× 50 0.6× 133 1.8× 41 0.7× 14 383
Frédéric Kridelka Belgium 10 195 1.8× 94 1.2× 96 1.2× 37 0.5× 48 0.8× 34 324
H. Crouet France 10 32 0.3× 53 0.7× 72 0.9× 74 1.0× 45 0.8× 27 299
K.J. Lohe Germany 11 222 2.1× 62 0.8× 174 2.2× 83 1.1× 17 0.3× 28 382
Vivian M. Spaans Netherlands 11 65 0.6× 73 0.9× 136 1.7× 125 1.7× 52 0.9× 13 350
Heather Foster United Kingdom 6 121 1.1× 70 0.9× 46 0.6× 99 1.4× 39 0.7× 11 421
G. C. Torre Italy 5 56 0.5× 78 1.0× 26 0.3× 69 0.9× 68 1.2× 8 325
Jining Feng United States 10 44 0.4× 98 1.2× 85 1.1× 116 1.6× 52 0.9× 20 296
Ji-Hong Hong Taiwan 10 171 1.6× 97 1.2× 149 1.9× 74 1.0× 41 0.7× 12 360
Sima Kadkhodayan Iran 8 163 1.5× 29 0.4× 69 0.9× 30 0.4× 77 1.4× 19 314

Countries citing papers authored by A. H. Tulusan

Since Specialization
Citations

This map shows the geographic impact of A. H. Tulusan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. H. Tulusan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. H. Tulusan more than expected).

Fields of papers citing papers by A. H. Tulusan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. H. Tulusan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. H. Tulusan. The network helps show where A. H. Tulusan may publish in the future.

Co-authorship network of co-authors of A. H. Tulusan

This figure shows the co-authorship network connecting the top 25 collaborators of A. H. Tulusan. A scholar is included among the top collaborators of A. H. Tulusan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. H. Tulusan. A. H. Tulusan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kühn, Thorsten, A. Bembenek, Thomas Decker, et al.. (2004). [Sentinel node biopsy in breast cancer].. PubMed. 43(1). 4–9. 2 indexed citations
2.
Wülfing, P, Christian Kersting, Barbara Sonntag, et al.. (2004). Expression of Endothelin-A-Receptor predicts unfavourable response to neoadjuvant chemotherapy in locally advanced breast cancer. British Journal of Cancer. 91(3). 434–440. 28 indexed citations
3.
Bembenek, A., Thomas Decker, Juergen Dunst, et al.. (2004). Sentinel node biopsy in breast cancer. Nuklearmedizin - NuclearMedicine. 43(1). 4–9. 3 indexed citations
4.
Minckwitz, G von, G. Raab, J. Hilfrich, et al.. (2001). Präoperative Chemotherapie operabler primärer Mammakarzinome mit einer dosisdichten Kombination von Adriamycin und Docetaxel (ADoc) - Die Erfahrungen der GEPARDO-GABG-Studiengruppe -. Zentralblatt für Gynäkologie. 123(9). 497–504. 4 indexed citations
5.
Wolff, E, et al.. (1997). Frequent gains and losses of specific chromosome segments in human ovarian carcinomas shown by comparative genomic hybridization. International Journal of Oncology. 11(1). 19–23. 16 indexed citations
6.
Ziegler, Volker, et al.. (1993). Stellenwert der Proliferationsfaktoren für nodalnedative Mammakarzinompatientinnen. Archives of Gynecology and Obstetrics. 254(1-4). 818–820. 2 indexed citations
7.
Bruntsch, U., S. Drechsler, W. Eiermann, et al.. (1992). Prevention of Chemotherapy-Induced Nausea and Emesis in Patients Responding Poorly to Previous Antiemetic Therapy. Drugs. 43(Supplement 3). 23–26. 12 indexed citations
8.
Burghardt, E., et al.. (1992). Results of surgical treatment of 1028 cervical cancers studied with volumetry. Cancer. 70(3). 648–655. 111 indexed citations
9.
Tulusan, A. H., et al.. (1991). Das diagnostische Problem des Lokalrezidivs nach brusterhaltender Therapie des Mammakarzinoms*. Geburtshilfe und Frauenheilkunde. 51(4). 262–266. 3 indexed citations
10.
Paolo, Marcello Di, et al.. (1990). Der Stellenwert der Skalenusbiopsie im Therapieplan des fortgeschrittenen Kollumkarzinoms. Geburtshilfe und Frauenheilkunde. 50(4). 310–313. 4 indexed citations
11.
Adam, R., et al.. (1989). Langzeitbeobachtungen von Patientinnen mit Borderline-Tumoren der Ovarien. Geburtshilfe und Frauenheilkunde. 49(12). 1039–1043. 2 indexed citations
12.
Jäger, W., et al.. (1989). Immunhistochemischer und serologischer Nachweis des CA-125 bei Patientinnen mit Peritonealtuberkulose und Aszites. Geburtshilfe und Frauenheilkunde. 49(1). 61–63. 9 indexed citations
13.
Adam, R., et al.. (1989). Erfahrungen mit der Drillbiopsie in der Diagnostik von Mammatumoren. Geburtshilfe und Frauenheilkunde. 49(5). 442–447.
14.
Tulusan, A. H., et al.. (1987). Stellenwert der radikalen Chirurgie bei der Behandlung des Ovarialkarzinoms. Archives of Gynecology and Obstetrics. 242(1-4). 404–406. 1 indexed citations
15.
Tulusan, A. H., et al.. (1982). Correlations of the receptor content and ultrastructure of breast cancer cells. Archives of Gynecology and Obstetrics. 231(3). 177–184. 6 indexed citations
16.
Tulusan, A. H., et al.. (1982). A contribution to the natural history of breast cancer. Archives of Gynecology and Obstetrics. 231(3). 219–226. 8 indexed citations
17.
Tulusan, A. H., et al.. (1982). A contribution to the natural history of breast cancer. Archives of Gynecology and Obstetrics. 231(3). 209–218. 12 indexed citations
18.
Haneke, Eckart, et al.. (1977). Histological features of ?pagetoid reticulosis? (woringer-Kolopp) in pre-Mycosis fungoides. Archives of Dermatological Research. 258(3). 265–273. 9 indexed citations
19.
Tulusan, A. H. & Guido Brandt. (1977). Morphologic differential diagnosis of idiopathic cardiomyopathies. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 374(1). 71–79. 7 indexed citations
20.
Tulusan, A. H., et al.. (1972). Ultrastructural changes produced by the carcinogen, aflatoxin B1, in different tissues. Virchows Archiv B Cell Pathology. 10(1). 275–285. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026